🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 3 study to evaluate the efficacy and safety of birtamimab plus stan...
Status
Terminated
Location
Yale Cancer Center
Start Date
2021-08-30
Trial ID
NCT04973137
Treatments Being Tested
The study will evaluate the effects of BHQ880 in patients with previously u...
Status
Completed
Location
University Chicago Hospital Dept. of Univ of Chicago (2)
Start Date
2012-01
Trial ID
NCT01337752
Treatments Being Tested
This study will be conducted in 2 parts. The phase 1b part will be an inter...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02605356
Treatments Being Tested
This was a Phase 3, multicenter, randomized, double blind, placebo-controll...
Status
Completed
Location
Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 156524
Start Date
2016-07-11
Trial ID
NCT02755597
Treatments Being Tested
The purpose of this study is to determine if there is an improvement in pro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-07
Trial ID
NCT01266811
Treatments Being Tested
The purpose of this study is to evaluate an investigational drug called tab...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-07
Trial ID
NCT01602224
Treatments Being Tested
This study evaluates the potential synergic anti-myeloma activity of clarit...
Status
Terminated
Location
Department of Hematology, Aalborg University Hospital
Start Date
2015-01
Trial ID
NCT02573935
Treatments Being Tested
Panobinostat (LBH589) is a highly potent pan-deacetylase inhibitor (pan-DAC...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-12-21
Trial ID
NCT01023308
Treatments Being Tested
Autoimmune Encephalitis is a disorder of the central nervous system caused ...
Status
Recruiting
Location
Ludwig-Maximilians-Universität München, Klinikum Großhadern
Start Date
2020-05-13
Trial ID
NCT03993262
Treatments Being Tested
The purpose of Part 1 of the study is to determine the safety of the combin...
Status
Completed
Location
Multiple Locations
Start Date
2006-11-28
Trial ID
NCT00401843
Treatments Being Tested